Deep Learning for Distinguishing Normal versus Abnormal Chest Radiographs and Generalization to Unseen Diseases
Authors:
Zaid Nabulsi,
Andrew Sellergren,
Shahar Jamshy,
Charles Lau,
Edward Santos,
Atilla P. Kiraly,
Wenxing Ye,
Jie Yang,
Rory Pilgrim,
Sahar Kazemzadeh,
Jin Yu,
Sreenivasa Raju Kalidindi,
Mozziyar Etemadi,
Florencia Garcia-Vicente,
David Melnick,
Greg S. Corrado,
Lily Peng,
Krish Eswaran,
Daniel Tse,
Neeral Beladia,
Yun Liu,
Po-Hsuan Cameron Chen,
Shravya Shetty
Abstract:
Chest radiography (CXR) is the most widely-used thoracic clinical imaging modality and is crucial for guiding the management of cardiothoracic conditions. The detection of specific CXR findings has been the main focus of several artificial intelligence (AI) systems. However, the wide range of possible CXR abnormalities makes it impractical to build specific systems to detect every possible conditi…
▽ More
Chest radiography (CXR) is the most widely-used thoracic clinical imaging modality and is crucial for guiding the management of cardiothoracic conditions. The detection of specific CXR findings has been the main focus of several artificial intelligence (AI) systems. However, the wide range of possible CXR abnormalities makes it impractical to build specific systems to detect every possible condition. In this work, we developed and evaluated an AI system to classify CXRs as normal or abnormal. For development, we used a de-identified dataset of 248,445 patients from a multi-city hospital network in India. To assess generalizability, we evaluated our system using 6 international datasets from India, China, and the United States. Of these datasets, 4 focused on diseases that the AI was not trained to detect: 2 datasets with tuberculosis and 2 datasets with coronavirus disease 2019. Our results suggest that the AI system generalizes to new patient populations and abnormalities. In a simulated workflow where the AI system prioritized abnormal cases, the turnaround time for abnormal cases reduced by 7-28%. These results represent an important step towards evaluating whether AI can be safely used to flag cases in a general setting where previously unseen abnormalities exist.
△ Less
Submitted 29 October, 2021; v1 submitted 21 October, 2020;
originally announced October 2020.
